Summary
Latest filing:
GNI Group Ltd. files SEC Form 4 reports at GYRE THERAPEUTICS, INC. (GYRE). 1 SEC Form 4 filing on record, dated 7 May 2026.
Trading pattern
InsiderAlpha's records for GNI Group Ltd. go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies GNI Group Ltd. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is GNI Group Ltd.?
GNI Group Ltd. is a corporate entity of GYRE THERAPEUTICS, INC. (GYRE). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did GNI Group Ltd. last file a Form 4?
The only primary Form 4 on record is dated 7 May 2026.